Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.13 | 0.7 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |